DuPont Nutrition & Health and AB-Biotics have signed a global collaboration and licensing agreement on AB-Life, a probiotic that is clinically documented to maintain healthy levels of cholesterol in at-risk individuals. Under the agreement, DuPont will have exclusive rights for the production, marketing and sales of AB-Life; and AB-Biotics will continue to conduct clinical research to further substantiate the proven health benefits of AB-Life. AB-Life is a patented probiotic formulation developed by AB-Biotics, based in Barcelona, Spain.

DuPont is integrating AB-Life into its documented HOWARU probiotic range for the dietary supplement and food and beverage industries. The company expects to launch the product in fourth quarter 2014.